TABLE 3.
Bivariate analysis of demographic and clinical factors associated with viral load suppression (< 1000 copies/mL) among patients receiving antiretroviral treatment (N = 6596).
| Demographic and clinical characteristics | Viral load suppression status |
P | |
|---|---|---|---|
| Not suppressed (%) | Suppressed (%) | ||
| When ART initiation occurred* | 0.003 | ||
| Pre-COVID-19 | 7.8 | 92.2 | |
| During COVID-19 | 4.3 | 95.7 | |
| Patient gender* | 0.047 | ||
| Male | 8.3 | 91.7 | |
| Female | 6.9 | 93.1 | |
| Rural or urban of the health zone* | < 0.001 | ||
| Urban | 8.9 | 91.1 | |
| Rural | 5.0 | 95.0 | |
| Age at the time of last visit** | 0.004 | ||
| Younger than 15 years | 12.1 | 87.9 | |
| 15 years or older | 7.2 | 92.8 | |
| Age at the time of last visit by gender** | 0.001 | ||
| < 15 years male | 11.5 | 88.5 | |
| < 15 years female | 10.2 | 89.8 | |
| 15–49.9 years male | 8.2 | 91.8 | |
| 15–49.9 years female | 7.1 | 92.9 | |
| ≥ 50 years male | 7.3 | 92.7 | |
| ≥ 50 years female | 4.7 | 95.3 | |
| TB status* | 0.805 | ||
| No TB | 7.4 | 92.6 | |
| TB present | 6.5 | 93.5 | |
Notes: Bold values show significance at P < 0.05. For this analysis, only 6596 patients for whom viral load data were available were retained in the analysis.Number of years on ART: odds ration = 1.0, P = 0.566.
ART, antiretroviral treatment; TB, tuberculosis; COVID-19, coronavirus disease 2019.
*
, P-values are based on Cramer’s V (nominal by ordinal).
**
, P-values are based on Somers’ D test (ordinal by ordinal).